LanzaTech Announces Progress on Strategic Actions to Sharpen Business Focus and Improve Cost Structure
LanzaTech Global (NASDAQ: LNZA) announced strategic actions to transform from an innovation hub to a profitable enterprise, implementing measures to achieve approximately $30 million in annual cash operating expense reductions. The company plans to:
1. Spin out its synthetic biology platform (LanzaX) and evaluate scale-up opportunities for LanzaTech Nutritional Protein (LNP)
2. Focus on core biorefining operations, particularly in waste-based ethanol to Sustainable Aviation Fuel (SAF) projects, including two 30-million gallon per year facilities in the UK and EU
3. Streamline operations by reducing workforce by 10-15% and consolidating global footprint
The company also rescheduled its Q4 and full-year 2024 earnings call to March 31, 2025, to align with its 10-K filing.
LanzaTech Global (NASDAQ: LNZA) ha annunciato azioni strategiche per trasformarsi da un centro di innovazione a un'impresa redditizia, implementando misure per ottenere circa 30 milioni di dollari in riduzioni annuali delle spese operative in contante. L'azienda prevede di:
1. Scorporare la sua piattaforma di biologia sintetica (LanzaX) e valutare opportunità di scalabilità per il LanzaTech Nutritional Protein (LNP)
2. Concentrarsi sulle operazioni di biorefining core, in particolare nei progetti di etanolo da rifiuti a carburante per aviazione sostenibile (SAF), inclusi due impianti da 30 milioni di galloni all'anno nel Regno Unito e nell'UE
3. Snellire le operazioni riducendo la forza lavoro del 10-15% e consolidando la presenza globale
L'azienda ha anche riprogrammato la sua chiamata sugli utili del quarto trimestre e dell'intero anno 2024 al 31 marzo 2025, per allinearsi con la sua presentazione del 10-K.
LanzaTech Global (NASDAQ: LNZA) anunció acciones estratégicas para transformarse de un centro de innovación a una empresa rentable, implementando medidas para lograr aproximadamente 30 millones de dólares en reducciones anuales de gastos operativos en efectivo. La empresa planea:
1. Desprender su plataforma de biología sintética (LanzaX) y evaluar oportunidades de escalado para LanzaTech Nutritional Protein (LNP)
2. Enfocarse en las operaciones de biorefinería centrales, particularmente en proyectos de etanol a partir de desechos para combustible de aviación sostenible (SAF), incluidos dos instalaciones de 30 millones de galones por año en el Reino Unido y la UE
3. Racionalizar las operaciones reduciendo la fuerza laboral en un 10-15% y consolidando su presencia global
La empresa también reprogramó su llamada de ganancias del cuarto trimestre y del año completo 2024 para el 31 de marzo de 2025, para alinearse con su presentación del 10-K.
란자텍 글로벌 (NASDAQ: LNZA)는 혁신 허브에서 수익성 있는 기업으로 전환하기 위한 전략적 조치를 발표하고, 연간 3천만 달러의 현금 운영 비용 절감을 달성하기 위한 조치를 시행할 계획입니다. 회사는 다음을 계획하고 있습니다:
1. 합성 생물학 플랫폼(LanzaX)을 분사하고 LanzaTech Nutritional Protein(LNP)의 확장 기회를 평가합니다.
2. 특히 폐기물 기반 에탄올에서 지속 가능한 항공 연료(SAF) 프로젝트로의 핵심 바이오리파이닝 운영에 집중하며, 영국과 EU에 연간 3천만 갤런 규모의 두 개 시설을 포함합니다.
3. 인력을 10-15% 줄이고 글로벌 입지를 통합하여 운영을 간소화합니다.
회사는 또한 2024년 4분기 및 연간 실적 발표를 2025년 3월 31일로 재조정하여 10-K 제출과 일치시켰습니다.
LanzaTech Global (NASDAQ: LNZA) a annoncé des actions stratégiques pour se transformer d'un pôle d'innovation en une entreprise rentable, en mettant en œuvre des mesures pour réaliser environ 30 millions de dollars d'économies annuelles sur les dépenses d'exploitation en espèces. L'entreprise prévoit de :
1. Démanteler sa plateforme de biologie synthétique (LanzaX) et d'évaluer les opportunités d'extension pour LanzaTech Nutritional Protein (LNP)
2. Se concentrer sur les opérations de biorefinage de base, en particulier dans les projets de transformation de l'éthanol à partir de déchets en carburant d'aviation durable (SAF), y compris deux installations de 30 millions de gallons par an au Royaume-Uni et dans l'UE
3. Rationaliser les opérations en réduisant la main-d'œuvre de 10 à 15 % et en consolidant son empreinte mondiale
L'entreprise a également reprogrammé son appel de résultats du quatrième trimestre et de l'année complète 2024 au 31 mars 2025, afin de s'aligner avec son dépôt 10-K.
LanzaTech Global (NASDAQ: LNZA) hat strategische Maßnahmen angekündigt, um sich von einem Innovationszentrum in ein profitables Unternehmen zu transformieren, und setzt Maßnahmen um, um jährlich etwa 30 Millionen Dollar an Betriebskosten in bar einzusparen. Das Unternehmen plant:
1. Die Abspaltung seiner synthetischen Biologie-Plattform (LanzaX) und die Bewertung von Skalierungsmöglichkeiten für LanzaTech Nutritional Protein (LNP)
2. Den Fokus auf die Kern-Biorefining-Operationen, insbesondere bei der Umwandlung von Abfall-Ethanol in nachhaltigen Flugkraftstoff (SAF)-Projekte, einschließlich zweier Anlagen mit einem Volumen von 30 Millionen Gallonen pro Jahr im Vereinigten Königreich und der EU
3. Die Rationalisierung der Abläufe durch eine Reduzierung der Belegschaft um 10-15 % und die Konsolidierung der globalen Präsenz
Das Unternehmen hat auch seinen Q4- und Gesamtjahresgewinnanruf für 2024 auf den 31. März 2025 verschoben, um mit der Einreichung seines 10-K übereinzustimmen.
- Strategic cost reduction of $30M annually
- Development of two major 30M gallon/year SAF facilities
- Strategic spinoff of LanzaX and LNP to access new capital
- Shift from R&D to commercial deployment focus
- 10-15% workforce reduction
- Delayed earnings report to March 31, 2025
Insights
LanzaTech's strategic restructuring announcement reveals a significant pivot from an R&D-focused innovation company to a commercially-oriented enterprise. The planned $30 million annual cash operating expense reductions represent a substantial cost-cutting initiative for a company with just a $134.5 million market cap.
The workforce reduction of 10-15% alongside facility consolidations demonstrates management's commitment to right-sizing operations. This restructuring comes as LanzaTech pursues a more focused approach on proven commercial technologies, particularly in waste-based ethanol to Sustainable Aviation Fuel (SAF).
The company's strategy to spin out its synthetic biology platform (LanzaX) and potentially its nutritional protein capabilities (LNP) appears designed to unlock value by allowing these platforms to secure independent funding while streamlining LanzaTech's core operations. This disaggregation strategy could potentially benefit each business unit by providing access to specialized capital sources and partners.
The prioritization of UK and EU waste-based ethanol-to-SAF facilities (each 30-million gallon per year) aligns with strong regulatory tailwinds for sustainable aviation fuel in those markets. By combining LanzaTech and LanzaJet CirculAir™ technologies, the company is positioning itself within an increasingly important segment of the energy transition.
While the earnings call rescheduling to align with the 10-K filing is procedurally reasonable, investors should monitor this reporting timeline carefully for any potential complications.
Executing initiatives to streamline priorities and drive approximately
Reschedules fourth quarter and full-year 2024 earnings conference call
CHICAGO, March 04, 2025 (GLOBE NEWSWIRE) -- LanzaTech Global, Inc. (NASDAQ: LNZA) (“LanzaTech” or the “Company”), a carbon management solutions company, today announced progress on strategic actions being taken to transition the Company from an innovation hub to a profitable enterprise. Additionally, the Company has rescheduled its fourth quarter and full-year 2024 earnings call to March 31, 2025, to more closely align with the filing of its Annual Report on Form 10-K.
“Over the last two decades, LanzaTech has been at the forefront of carbon management innovation, pushing the boundaries to establish new products and markets," said Dr. Jennifer Holmgren, Chair and CEO of LanzaTech. “As we shift the Company’s focus from research and development to globally deploying our proven technology, we are pursuing partnership opportunities for technologies that are ready to stand on their own and sharpening our focus on high-impact commercial projects that align more with a path to profitability. As part of this transition, we continue to action plans to right-size our cost structure and expect to achieve significant annual cash cost savings as a result.”
Along with the recently announced intention to spin out the Company’s synthetic biology platform referred to as LanzaX, LanzaTech is evaluating scale up opportunities for its nutritional protein capabilities referred to as LanzaTech Nutritional Protein (“LNP”). This strategic approach is designed to enable these platforms to access the capital required to accelerate the development of their independent pipelines of existing projects. It will also enable LanzaTech to have a sharper focus on the growth priorities of the Company’s core biorefining operations, including the technology’s inclusion in integrated waste-based ethanol to Sustainable Aviation Fuel (“SAF”).
Examples of high-priority commercial projects under development include a project in the United Kingdom and a project in the European Union, each 30-million gallon per year, waste-based ethanol-to-SAF facilities that will leverage the LanzaTech and LanzaJet CirculAir™ solution to form an efficient and economically compelling offering that provides the aviation industry with a platform to produce waste-based SAF globally.
Additionally, the Company is implementing strategic measures to scale its business globally with greater cost efficiency. This includes evaluating its global footprint, with anticipated consolidations expected to reduce the workforce by approximately 10 to 15 percent. These measures, combined with the LanzaX and LNP strategic opportunities, and other cost savings plans, have the potential to result in approximately
LanzaTech Reschedules Fourth Quarter and Full-Year 2024 Earnings Call
The Company announced today that it has rescheduled its previously announced earnings release and conference call. The Company now intends to release its fourth quarter and full-year 2024 earnings results on Monday, March 31, 2025, and host its conference call the same day at 8:30 a.m. Eastern Time. The change is to more closely align the Company’s earnings call with the filing of its Annual Report on Form 10-K.
The conference call may be accessed via a live webcast on a listen-only basis through the Events and Presentations section of LanzaTech’s Investor Relations website. An archive of the webcast will be available for twelve months.
To attend the live conference call via telephone, domestic callers can access by dialing (800) 225-9448 and international callers can access by dialing (203) 518-9708, and using the conference identification code LANZA.
A replay of the conference call will be available shortly after the call ends and can be accessed by domestic callers by dialing (844)-512-2921 and by international callers by dialing (412)-317-6671, and entering the access identification code 11157950. The replay will be available until 11:59 pm Eastern Time April 14, 2025.
About LanzaTech
LanzaTech Global, Inc. (NASDAQ: LNZA) is a leading carbon recycling company transforming waste carbon into sustainable fuels, chemicals, materials, and protein for everyday products. Using its bio-recycling technology, LanzaTech captures carbon generated by energy-intensive industries at the source, preventing it from being emitted into the air. LanzaTech then gives that captured carbon a new life as a clean replacement for virgin fossil carbon in everything from household cleaners and clothing fibers to packaging and fuels. By partnering with companies across the global supply chain like ArcelorMittal, Coty, Craghoppers, and LanzaJet, LanzaTech is paving the way for a circular carbon economy. For more information about LanzaTech, visit https://lanzatech.com.
Forward Looking Statements
This press release includes forward-looking statements regarding, among other things, the plans, strategies, and prospects, both business and financial, of LanzaTech. These statements are based on the beliefs, assumptions, projections and conclusions of LanzaTech’s management. Forward-looking statements are inherently subject to risks, uncertainties and assumptions, many of which are outside LanzaTech’s control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. LanzaTech cannot assure you that it will achieve or realize these plans, intentions or expectations. Forward-looking statements are not guarantees of future performance, conditions or results, and you should not rely on forward-looking statements.
Generally, statements that are not historical facts, including those concerning possible or assumed future actions, business strategies, events or results of operations, are forward-looking statements. These statements may be preceded by, followed by or include the words “believes,” “estimates,” “expects,” “projects,” “forecasts,” “may,” “will,” “should,” “seeks,” “plans,” “scheduled,” “anticipates,” “intends” or similar expressions. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the following: timing delays in the advancement of projects to the final investment decision stage or into construction; failure by customers to adopt new technologies and platforms; fluctuations in the availability and cost of feedstocks and other process inputs; the availability and continuation of government funding and support; broader economic conditions, including inflation, interest rates, supply chain disruptions, employment conditions, and competitive pressures; unforeseen technical, regulatory, or commercial challenges in scaling proprietary technologies, business functions or operational disruptions; and other economic, business, or competitive factors, and other risks and uncertainties, including the risk factors and other information contained in LanzaTech’s most recent Annual Report on Form 10-K and any subsequent Quarterly Reports on Form 10-Q, as well as other existing and future filings with the U.S. Securities and Exchange Commission.
Any forward-looking statement herein is based only on information currently available to LanzaTech and speaks only as of the date on which it is made. LanzaTech undertakes no obligations to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
Contacts:
Kate Walsh
VP, Investor Relations
Investor.Relations@lanzatech.com
FAQ
How much cost reduction is LanzaTech (LNZA) targeting through its strategic restructuring?
What are the key projects LanzaTech (LNZA) is focusing on in 2025?
How many employees will be affected by LanzaTech's (LNZA) workforce reduction in 2025?
What strategic spinoffs is LanzaTech (LNZA) pursuing in 2025?
